BioWorld

Aug. 6, 2010

Analysis SORTs Out Blood Lipids, Heart Disease Risk

NewCo News: Sweden's BioChromix Pharma Tackles AD's Amyloid Cascade

Alexza Slides on $18M Stock Offering, PDUFA Date Ahead

Alexza Pharmaceuticals Inc. is raising $18 million in a registered direct offering of stock and warrants, news that sent shares of the Mountain View, Calif.-based firm falling 18 percent Thursday. (BioWorld Today) Read More

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld

Aug. 6, 2010

Analysis SORTs Out Blood Lipids, Heart Disease Risk

NewCo News: Sweden's BioChromix Pharma Tackles AD's Amyloid Cascade

Other News To Note

Stock Movers

Clinic Roundup

Appointments And Advancements

Earnings Roundup

Alexza Slides on $18M Stock Offering, PDUFA Date Ahead

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors

Today's news in brief

Today's news in brief

Second insulin receptor offers new therapeutic avenues

Mechanism underlying so-called idiopathic autism inception unveiled

Drug duo to Repare lack in gyno cancers? Phase I shows promise